Renal function changes and NHS resource use in breast cancer patients with metastatic bone disease treated with IV zoledronic acid or oral ibandronic acid: a four-centre non-interventional study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples